Cardiac involvement from amyloidosis is of growing interest in the overall literature. Despite cardiac amyloidosis (CA) has been considered for a long time a rare disease, the diagnostic awareness is increasing mainly thanks to the improvement of diagnostic softwares and of imaging techniques such as cardiac magnetic resonance (CMR). Some authors have observed an increase of prevalence rate of CA; moreover it’s often underestimated because clinical manifestations are aspecific. The interstitial infiltration of the left ventricle has been extensively studied, while the involvement of the right ventricle (RV) has been less investigated. Involvement of the RV, even in the absence of pulmonary hypertension or clearly left ventricle infiltration, plays an important role as prognostic factor and is useful to achieve an early diagnosis. Therefore, the use of fast and low-cost diagnostic methods such as ultrasound strain of the right ventricle could be used to recognize cardiac amyloidosis early. Herein the importance of evaluating the right ventricular involvement, which can predict the most severe course of the disease also without overt clinical manifestations. The role of imaging, in particular of echocardiography, CMR, and scintigraphy is here reported.
CITATION STYLE
Tana, M., Tana, C., Palmiero, G., Mantini, C., Coppola, M. G., Limongelli, G., … Porreca, E. (2023, September 1). Imaging findings of right cardiac amyloidosis: impact on prognosis and clinical course. Journal of Ultrasound. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s40477-023-00789-1
Mendeley helps you to discover research relevant for your work.